Skip to main content
MEHA
NASDAQ Life Sciences

Shareholders Approve Reverse Stock Split to Avoid Delisting and New Equity Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Neutral
Importance info
9
Price
$0.082
Mkt Cap
$3.548M
52W Low
$0.057
52W High
$8
52W Position info
45% above low
Off High info
99% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MEHA sits 45% above its 52-week low of $0.057.

Summary

Functional Brands shareholders approved a reverse stock split, a crucial move to prevent Nasdaq delisting, and also authorized a new equity incentive plan.


Key Events · Corporate Governance and Compliance · MEHA

  • Reverse Stock Split Approved

    Shareholders approved an amendment to the Certificate of Incorporation, granting the Board of Directors discretion to effect a reverse stock split at a ratio between 1:2 and 1:250 within one year. This is a critical step to address the company's Nasdaq delisting threat.

  • Equity Incentive Plan Approved

    The Functional Brands Inc. 2026 Equity Incentive Plan was approved by shareholders, allowing the company to grant equity awards for compensation and retention.


Analysis · MEHA · Life Sciences

Shareholders have approved the Board's discretion to implement a reverse stock split, a critical step for Functional Brands Inc. to address its Nasdaq delisting threat due to its low share price. This action is essential for the company to potentially regain compliance with Nasdaq's minimum bid price requirement. Additionally, the approval of the 2026 Equity Incentive Plan provides the company with a mechanism for employee compensation and retention.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MEHA was trading at $0.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.06 to $8.00. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Aug 17, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.004847
Real-time Price: $0.0051 info
Change: +$0.000253 (+5%) info
Market Cap: $331.098K info
MEHA
Aug 14, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0049
Real-time Price: $0.0051 info
Change: +$0.0002 (+4%) info
Market Cap: $331.098K info
MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0043
Real-time Price: $0.0051 info
Change: +$0.0008 (+19%) info
Market Cap: $331.098K info
MEHA
Jun 30, 2026, 6:46 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0052
Real-time Price: $0.0051 info
Change: -$0.0001 (-2%) info
Market Cap: $331.098K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0416
Real-time Price: $0.0051 info
Change: -$0.0365 (-88%) info
Market Cap: $331.098K info